Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Target price


06:47 / Tradegate WKN: A1XEAC / Symbol: CNCE / Name: Concert Pharma / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Concert Pharmaceuticals Inc. Stock

Concert Pharmaceuticals Inc. gained 0.180% compared to yesterday.
So far the community has only identified positive things for Concert Pharmaceuticals Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Concert Pharmaceuticals Inc. in the next few years

W********* I********* f** t** n*** y****
C******** o* t** e**********
M***** P*******
S********** s********
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Concert Pharmaceuticals Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Concert Pharmaceuticals Inc. 0.180% 0.000% 0.000% - 56.305% - -
Brainstorm Cell 0.730% -2.837% -0.725% 1.182% 93.230% -54.711% -
Sorrento Therapeutics Inc. -24.520% 0.000% 0.000% -81.488% -65.296% -93.763% -
Atara Biotherapeutics Inc. -5.350% -15.529% -32.974% -66.065% -44.577% -83.812% -


Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) is now covered by analysts at They set a "sell" rating on the stock.
Ratings data for CNCE provided by MarketBeat
Show more